Results of a Randomized, Double-Blind Phase II Clinical Trial of NY-ESO-1 Vaccine with ISCOMATRIX Adjuvant Versus ISCOMATRIX Alone in Participants with High-Risk Resected Melanoma. Jonathan S. Cebon , Martin Gore , John F. Thompson , Ian D. Davis , Grant A. McArthur , Euan Walpole , Mark Smithers , Vincenzo Cerundolo , P. Rod Dunbar , Duncan MacGregor , Cyril Fisher , Michael Millward , Paul Nathan , Michael P. N. Findlay , Peter Hersey , T. R. Jeffry Evans , Christian Hermann Ottensmeier , Jeremy Marsden , Angus G. Dalgleish , Pippa G. Corrie , Marples Maria , Margaret Brimble , Geoff Williams , Sintia Winkler , Heather M. Jackson , Liliana Endo-Munoz , Candani S. A. Tutuka , Ralph Venhaus , Lloyd J. Old , Dennis Haack , Eugene Maraskovsky , Andreas Behren , Weisan Chen Journal for ImmunoTherapy of Cancer（2020）
关键词
oncology, immunology, tumours, randomised trials, HLA
AI 理解论文
溯源树
样例
